612 related articles for article (PubMed ID: 15497158)
1. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
[TBL] [Abstract][Full Text] [Related]
2. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
[TBL] [Abstract][Full Text] [Related]
3. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract][Full Text] [Related]
4. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
[TBL] [Abstract][Full Text] [Related]
6. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.
Figueras J; Ibañez L; Ramos E; Jaurrieta E; Ortiz-de-Urbina J; Pardo F; Mir J; Loinaz C; Herrera L; López-Cillero P; Santoyo J
Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.
Yao FY; Ferrell L; Bass NM; Bacchetti P; Ascher NL; Roberts JP
Liver Transpl; 2002 Sep; 8(9):765-74. PubMed ID: 12200775
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era.
Levi DM; Tzakis AG; Martin P; Nishida S; Island E; Moon J; Selvaggi G; Tekin A; Madrazo BL; Narayanan G; Garcia MT; Feun LG; Tryphonopoulos P; Skartsis N; Livingstone AS
J Am Coll Surg; 2010 May; 210(5):727-34, 735-6. PubMed ID: 20421039
[TBL] [Abstract][Full Text] [Related]
9. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
11. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
Austin MT; Leys CM; Feurer ID; Lovvorn HN; O'Neill JA; Pinson CW; Pietsch JB
J Pediatr Surg; 2006 Jan; 41(1):182-6. PubMed ID: 16410130
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
17. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
[TBL] [Abstract][Full Text] [Related]
18. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
[TBL] [Abstract][Full Text] [Related]
20. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]